HF Sinclair Corp., Dallas, plans to slightly increase its capital spending on growth projects in 2025 but keep its overall capex in line with this year’s forecast. In a recent filing with the US ...
Morning Overview on MSN
A Harvard scientist says his team is preparing the first human trials aimed at reversing aging
A team linked to Harvard Medical School has dosed the first patient in a clinical trial designed to reverse cellular aging in ...
UNIC Athens has launched its new Evolve Lecture Series with an inaugural lecture by David Sinclair, Professor of Genetics at ...
A federal judge allowed most of a whistleblower lawsuit against Harvard to proceed Tuesday, letting two claims advance in a ...
As we age, so do our cells. But some scientists are wondering if we actually need to accept this inevitable entropy.On June 9 ...
Worrying about ageing itself might be accelerating the process, a study on midlife women suggests. Beyond common factors like ...
They say money can’t buy you love. But can it buy you eternal life? Authoritarians expect it. A bevy of billionaires are banking on it. And the drive to deliver the holy grail of health care is a race ...
The first participant has been treated in a landmark clinical trial of cellular reprogramming, which aims to rejuvenate aging ...
Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before.
24d
The world's first anti-ageing gene therapy has just been injected into a human - here's what it does
World’s first anti-ageing gene therapy trial begins as ER-100 is injected into a human eye, testing partial cellular reprogramming to restore vision and fight ageing ...
An eagerly awaited and controversial clinical trial to 'wind back the clock' on aging cells in the eye and restore them to a more youthful state has officially begun.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results